{
  "trial_id": "NCT02294474",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 2 diabetes mellitus, baseline HbA1c, fasting plasma glucose (FPG), self-measured plasma glucose (SMPG) profiles, insulin dose, body mass index (BMI), presence of diabetic retinopathy, prior use of insulin glargine, prior use of Humalog/Liprolog or NovoLog/NovoRapid, hospitalization for diabetic ketoacidosis, immunogenicity status (positive/negative), antibody titers.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body mass index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Duration of type 2 diabetes mellitus (T2DM)",
          "duration of type 2 diabetes mellitus"
        ],
        [
          "HbA1c %",
          "baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Previous meal time insulin",
        "Randomization Strata of Screening HbA1c",
        "Average Daily Basal Insulin Dose",
        "Average Daily Mealtime Insulin Dose",
        "Average Daily Total Insulin Dose"
      ],
      "remaining_candidate_features": [
        "fasting plasma glucose (FPG)",
        "self-measured plasma glucose (SMPG) profiles",
        "insulin dose",
        "presence of diabetic retinopathy",
        "prior use of insulin glargine",
        "prior use of Humalog/Liprolog or NovoLog/NovoRapid",
        "hospitalization for diabetic ketoacidosis",
        "immunogenicity status (positive/negative)",
        "antibody titers."
      ]
    },
    "processed-gen-response": "Age, gender, duration of type 2 diabetes mellitus, baseline HbA1c, fasting plasma glucose (FPG), self-measured plasma glucose (SMPG) profiles, insulin dose, body mass index (BMI), presence of diabetic retinopathy, prior use of insulin glargine, prior use of Humalog/Liprolog or NovoLog/NovoRapid, hospitalization for diabetic ketoacidosis, immunogenicity status (positive/negative), antibody titers."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Self-measured Plasma Glucose, Insulin Dose, Body Mass Index,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body mass index (BMI)",
          "Body Mass Index"
        ],
        [
          "Duration of type 2 diabetes mellitus (T2DM)",
          "Duration of Diabetes"
        ],
        [
          "HbA1c %",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Previous meal time insulin",
        "Randomization Strata of Screening HbA1c",
        "Average Daily Basal Insulin Dose",
        "Average Daily Mealtime Insulin Dose",
        "Average Daily Total Insulin Dose"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Fasting Plasma Glucose",
        "Self-measured Plasma Glucose",
        "Insulin Dose"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Self-measured Plasma Glucose, Insulin Dose, Body Mass Index"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Diagnosis Duration, Baseline HbA1c, Fasting Plasma Glucose, Self-Measured Plasma Glucose, Insulin Dose, Body Mass Index.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body mass index (BMI)",
          "Body Mass Index"
        ],
        [
          "Duration of type 2 diabetes mellitus (T2DM)",
          "Diabetes Diagnosis Duration"
        ],
        [
          "HbA1c %",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Previous meal time insulin",
        "Randomization Strata of Screening HbA1c",
        "Average Daily Basal Insulin Dose",
        "Average Daily Mealtime Insulin Dose",
        "Average Daily Total Insulin Dose"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Fasting Plasma Glucose",
        "Self-Measured Plasma Glucose",
        "Insulin Dose"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Region of Enrollment, Diabetes Diagnosis Duration, Baseline HbA1c, Fasting Plasma Glucose, Self-Measured Plasma Glucose, Insulin Dose, Body Mass Index."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus (T2DM), HbA1c at baseline, fasting plasma glucose (FPG) at baseline, self-measured plasma glucose (SMPG) at baseline, insulin dose at baseline, history of diabetic complications, history of cardiovascular disease, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body mass index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Duration of type 2 diabetes mellitus (T2DM)",
          "duration of type 2 diabetes mellitus (T2DM)"
        ],
        [
          "HbA1c %",
          "HbA1c at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Previous meal time insulin",
        "Randomization Strata of Screening HbA1c",
        "Average Daily Basal Insulin Dose",
        "Average Daily Mealtime Insulin Dose",
        "Average Daily Total Insulin Dose"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "fasting plasma glucose (FPG) at baseline",
        "self-measured plasma glucose (SMPG) at baseline",
        "insulin dose at baseline",
        "history of diabetic complications",
        "history of cardiovascular disease",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus (T2DM), HbA1c at baseline, fasting plasma glucose (FPG) at baseline, self-measured plasma glucose (SMPG) at baseline, insulin dose at baseline, history of diabetic complications, history of cardiovascular disease, smoking status."
  }
}